Jens Faber

Jens Faber

Professor, emeritus


Publication year:
All
41 - 50 out of 168Page size: 10
  1. 2020
  2. Published

    High-Dose Glucagon Has Hemodynamic Effects Regardless of Cardiac Beta-Adrenoceptor Blockade: A Randomized Clinical Trial

    Petersen, K. M., Bøgevig, S., Riis, T., Andersson, N. W., Dalhoff, Kim, Holst, Jens Juul, Knop, Filip Krag, Faber, Jens, Petersen, Tonny Studsgaard & Christensen, Mikkel Bring, 2020, In: Journal of the American Heart Association. 9, 21, 27 p., e016828.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Endogenous Testosterone Levels Are Associated with Risk of Type 2 Diabetes in Women without Established Comorbidity

    Rasmussen, J. J., Selmer, C., Frøssing, S., Schou, Morten, Faber, Jens, Torp-Pedersen, C. T., Gislason, Gunnar Hilmar, Køber, Lars Valeur, Hougaard, D. M., Cohen, A. S. & Kistorp, Caroline Michaela Nervil, 2020, In: Endocrine Research. 4, 6, 11 p., bvaa050.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Editorial commentary: Subclinical thyroid dysfunction and cardiovascular risk: Nothing to lose, everything to gain?

    Selmer, C. & Faber, Jens, 2020, In: Trends in Cardiovascular Medicine. 30, 2, p. 70-71

    Research output: Contribution to journal › Editorial › Research

  5. Impact of a 4-Week Intensified Endurance Training Intervention on Markers of Relative Energy Deficiency in Sport (RED-S) and Performance Among Well-Trained Male Cyclists

    Stenqvist, T. B., Torstveit, M. K., Faber, Jens & Melin, A. K., 2020, In: Frontiers in Endocrinology. 11, 11 p., 512365.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. 2019
  7. Published

    Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors

    Eickhoff, M. K., Dekkers, C. C. J., Kramers, B. J., Laverman, G. D., Frimodt-Møller, M., Jørgensen, Niklas Rye, Faber, Jens, Danser, A. H. J., Gansevoort, R. T., Rossing, Peter, Persson, F. & Heerspink, H. J. L., 31 May 2019, In: Journal of Clinical Medicine. 8, 6

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Long-Term Outcome in Patients With Heart Failure Treated With Levothyroxine: An Observational Nationwide Cohort Study

    Einfeldt, M. N., Olsen, A. S., Kristensen, S. L., Khalid, U., Faber, Jens, Torp-Pedersen, C., Gislason, Gunnar Hilmar & Selmer, C., 2019, In: Journal of Clinical Endocrinology and Metabolism. 104, 5, p. 1725-1734

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Prevalence of early stages of heart failure in an elderly risk population: The Copenhagen Heart Failure Risk Study

    Gaborit, F. S., Kistorp, Caroline Michaela Nervil, Kümler, T., Hassager, Christian, Tønder, N., Køber, Lars Valeur, Hansen, P. M., Kamstrup, P. R., Faber, Jens, Iversen, Kasper & Schou, Morten, 2019, In: Open Heart. 6, 1, 12 p., e000840.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Prevalence of heart failure and the diagnostic value of MR-proANP in outpatients with type 2 diabetes

    Jensen, J., Schou, Morten, Kistorp, Caroline Michaela Nervil, Faber, Jens, Hansen, T. W., Jensen, M. T., Andersen, H. U., Rossing, Peter, Vilsbøll, Tina & Jørgensen, P. G., 2019, In: Diabetes, Obesity and Metabolism. 21, 3, p. 736-740 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes

    Johansen, M. L., Schou, Morten, Rasmussen, J., Rossignol, P., Holm, M. R., Chabanova, E., Dela, Flemming, Faber, Jens & Kistorp, Caroline Michaela Nervil, 2019, In: Diabetes & Metabolism. 45, 5, p. 429-435

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial (MIRAD trial)

    Johansen, M. L., Schou, Morten, Rossignol, P., Holm, M. R., Rasmussen, J., Brandt, N., Frandsen, M., Chabanova, E., Dela, Flemming, Faber, Jens & Kistorp, Caroline Michaela Nervil, 2019, In: Diabetes, Obesity and Metabolism. 21, 10, p. 2305-2314 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...17 Next

ID: 358461459